RecruitingPhase 2NCT04414046

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Studying Primary immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Johns Hopkins All Children's Hospital
Principal Investigator
Deepak Chellapandian, MD
Johns Hopkins All Children's Hospital
Intervention
Haploidentical Hematopoietic Cell Transplantation(biological)
Enrollment
17 enrolled
Eligibility
21 years · All sexes
Timeline
20202026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04414046 on ClinicalTrials.gov

Other trials for Primary immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Primary immunodeficiency

← Back to all trials